Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03090646 · ClinicalTrials.gov registry record · NA
Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance
A NA study of Nephrectomy and Living Donors, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 320
- Enrollment target
- 2
- Study locations
NCT03090646: Active NA study of Nephrectomy and Living Donors, sponsored by Johns Hopkins University.
NCT03090646 is a NA study of Nephrectomy and Living Donors that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 320 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03090646, a NA study of Nephrectomy and Living Donors, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates whether using small financial incentives increases patient compliance with nationally-mandated living kidney donor follow-up at 6-months, 1-year, and 2-years after donation. Half of participants will receive a financial incentive (mailed gift card) after completing required follow-up activities (brief questionnaire and lab draw), while the other half will be asked to complete the required follow-up activities but will not receive a financial incentive (current standard of care).
Primary Outcome
Rate of policy-defined complete (all components addressed) and timely (within 60 days before or after the 6-month, 1-year, or 2-year post donation date; i.e. 120-day period) submission of data at 6-month, 1-year, and 2-year follow-up visits (assessed separately for each follow-up time point and as a composite outcome over the study period).
Conditions Studied
Interventions
- OTHER Financial Incentive
Study Locations (2)
Maryland
- University of Maryland Medical Center Transplant Center - Baltimore
- The Johns Hopkins Hospital Comprehensive Transplant Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2017-03-22 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
What the registry record for NCT03090646 still lists
NCT03090646 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 3 conditions, with Nephrectomy appearing as the primary indexed condition, and to 1 intervention - of which Financial Incentive is the first listed.
NCT03090646 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03090646 about?
NCT03090646 is a clinical study titled "Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance". This study evaluates whether using small financial incentives increases patient compliance with nationally-mandated living kidney donor follow-up at 6-months, 1-year, and 2-years after donation. Half of participants will receive a financial incentive (mailed gift card) after completing required foll...
What is the current status of trial NCT03090646?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2017-03-22. Estimated completion is 2026-08-01.
What conditions does trial NCT03090646 study?
This clinical trial studies the following conditions: Nephrectomy, Living Donors, Kidney.
What interventions are being tested in trial NCT03090646?
The interventions under investigation include: Financial Incentive (OTHER).
Who is sponsoring clinical trial NCT03090646?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03090646 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03090646's enrollment target sits among peer trials
320 315th of 2000 higher than 1,680 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI